Ishares Msci Brazil ETF (EWZ) Stock Price Today
Aura AI Summary
Key Stats
- $11.29BMarket Cap
- 298,643,009Volume
- Broad Market / FactorSector
- $43.5452W High
- $30.7752W Low
- 46 DaysTypical Hold Time
- -Enterprise Value
- -Div Yield
- 94% Sell | 6% BuyTrading Activity
Track Ishares Msci Brazil ETF (EWZ) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ishares Msci Brazil ETF has traded between a low of $30.77 and a high of $43.54, highlighting its annual price range. Buy and sell Ishares Msci Brazil ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Ishares Msci Brazil ETF
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Most Recent News
India's plastics market to reach $68.41B by 2032, driven by packaging and electric vehicle demand.
India's plastics industry is projected to grow from USD 49.98 billion in 2027 to USD 68.41 billion by 2032, at a CAGR of 6.48%. Growth is fueled by rising demand in packaging, pharmaceuticals, electric two-wheelers, and construction, alongside polyme...

Xylem misses Q3 revenue by $80M, EPS below estimates, sparking securities law probe.
Xylem Inc. reported third-quarter revenue of approximately $2.20 billion, missing Wall Street's estimate by about $80 million and falling short of its own projections. Adjusted earnings per share were $1.44, slightly below the consensus of $1.45. The...

Class action filed against Tenax Therapeutics over misleading drug trial results causing stock plunge.
Tenax Therapeutics faces a class action lawsuit for allegedly misleading investors about the effectiveness of its drug levosimendan during clinical trials. The company claimed positive results from earlier studies, but its Phase 3 trial failed to mee...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.